These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Interleukin-33: from biology to potential treatments]. Schmitt P; Girard JP; Cayrol C Med Sci (Paris); 2019 May; 35(5):440-451. PubMed ID: 31115327 [TBL] [Abstract][Full Text] [Related]
27. The paradigm of cytokine networks in allergic airway inflammation. Pawankar R; Hayashi M; Yamanishi S; Igarashi T Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):41-8. PubMed ID: 25479317 [TBL] [Abstract][Full Text] [Related]
28. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. Gold MJ; Antignano F; Halim TY; Hirota JA; Blanchet MR; Zaph C; Takei F; McNagny KM J Allergy Clin Immunol; 2014 Apr; 133(4):1142-8. PubMed ID: 24679471 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis. Ge Y; Huang M; Yao YM Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411 [TBL] [Abstract][Full Text] [Related]
30. IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants. Ranasinghe C; Trivedi S; Wijesundara DK; Jackson RJ Cytokine Growth Factor Rev; 2014 Aug; 25(4):437-42. PubMed ID: 25159217 [TBL] [Abstract][Full Text] [Related]
31. Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury. Chen WY; Li LC; Wu YH; Yang JL; Tzeng HT Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102434 [TBL] [Abstract][Full Text] [Related]
32. Role of innate and adaptive immunity in obesity-associated metabolic disease. McLaughlin T; Ackerman SE; Shen L; Engleman E J Clin Invest; 2017 Jan; 127(1):5-13. PubMed ID: 28045397 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. Cayrol C; Girard JP Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993 [TBL] [Abstract][Full Text] [Related]
34. Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Saenz SA; Noti M; Artis D Trends Immunol; 2010 Nov; 31(11):407-13. PubMed ID: 20951092 [TBL] [Abstract][Full Text] [Related]
35. Type 2 cytokines: mechanisms and therapeutic strategies. Wynn TA Nat Rev Immunol; 2015 May; 15(5):271-82. PubMed ID: 25882242 [TBL] [Abstract][Full Text] [Related]
36. The 3 major types of innate and adaptive cell-mediated effector immunity. Annunziato F; Romagnani C; Romagnani S J Allergy Clin Immunol; 2015 Mar; 135(3):626-35. PubMed ID: 25528359 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. Mantovani A; Dinarello CA; Molgora M; Garlanda C Immunity; 2019 Apr; 50(4):778-795. PubMed ID: 30995499 [TBL] [Abstract][Full Text] [Related]
38. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review. De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562 [TBL] [Abstract][Full Text] [Related]